COSMOS(SZ:300856)2024-04-16 13:32Dividend and Shareholder Returns - The company plans to distribute a cash dividend of 15 RMB per 10 shares (including tax) to all shareholders, based on a total of 169,333,487 shares[21]. - The company has not issued any bonus shares during the reporting period, maintaining a focus on cash dividends[21]. - The company has a total of 169,333,487 shares outstanding, which is the basis for the profit distribution plan[21]. Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB, representing a year-over-year growth of 15%[32]. - The company's operating revenue for 2023 reached ¥2,399,920,217.58, representing a 35.99% increase compared to ¥1,764,816,558.96 in 2022[34]. - Net profit attributable to shareholders for 2023 was ¥733,587,263.70, an increase of 89.02% from ¥388,143,580.49 in 2022[34]. - The net profit after deducting non-recurring gains and losses was ¥715,454,749.18, up 89.11% from ¥378,354,819.42 in the previous year[34]. - Basic earnings per share for 2023 were ¥4.3325, reflecting an 88.99% increase from ¥2.2924 in 2022[34]. - Diluted earnings per share for 2023 were ¥4.0975, which is a 78.74% increase from ¥2.2924 in the previous year[34]. - The total assets at the end of 2023 amounted to ¥3,890,408,276.66, a 71.31% increase from ¥2,270,529,857.01 in 2022[34]. - Net assets attributable to shareholders at the end of 2023 were ¥2,626,950,500.64, up 35.03% from ¥1,945,455,860.63 in 2022[34]. - The weighted average return on equity for 2023 was 32.15%, an increase of 10.16% compared to 21.99% in 2022[34]. Market and Product Development - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 10% to 12%[32]. - New product launches are expected to contribute an additional 200 million RMB in revenue, with a focus on personal care products[32]. - The company is investing in R&D, allocating 10% of its revenue towards developing new technologies and products[32]. - Market expansion plans include entering two new international markets by the end of the next fiscal year[32]. - The company is considering strategic acquisitions to enhance its product portfolio and market presence[32]. - A new marketing strategy will be implemented, aiming to increase brand awareness by 25% over the next year[32]. Environmental and Social Responsibility - The report includes a section on environmental and social responsibility, highlighting the company's commitment to these areas[23]. - The company is committed to improving safety and quality management levels, which enhances its overall competitive strength and risk resistance capabilities[62]. - The company is focusing on the development of safe and non-irritating cosmetic active ingredients, aligning with consumer preferences for quality and safety[58]. - The company has received environmental impact approval for a project to expand the production of sunscreen products by 5,000 tons annually, indicating ongoing growth and capacity enhancement[66]. Research and Development - The company has applied for 18 new patents and received 15 patent grants during the reporting period, including 7 invention patents[96]. - The company is in the laboratory research phase for several new product lines, including titanium dioxide and zinc oxide series for physical sunscreen, aimed at expanding its market presence[123]. - The company is currently constructing a high-end personal care product R&D center in Nanjing Jiangning Economic and Technological Development Zone[180]. - The company will invest in research and development in cosmetic applications and formulations, collaborating with hospitals and research institutions to improve service precision and value[189]. Risk Management and Governance - The company has outlined potential risks and corresponding countermeasures in the section discussing future development prospects[5]. - The company emphasizes the accuracy and completeness of the financial report, with all board members present for the meeting[4]. - The company has not disclosed any significant changes in its registered address during the reporting period[14]. - The company has not made any significant changes to its governance structure[23]. - The company adheres to legal regulations and governance standards, continuously improving its governance structure and operational norms[197]. - There are no significant discrepancies between the company's governance practices and the regulations set by the China Securities Regulatory Commission[198]. - The company maintains complete independence in assets, personnel, finance, and operations from existing shareholders and related parties, ensuring autonomous market operations[199]. Cash Flow and Investment - The net cash flow from operating activities for 2023 was ¥798,883,526.88, a significant increase of 178.14% compared to ¥287,219,044.00 in 2022[34]. - The total cash inflow from operating activities was ¥2,500,188,084.82, a 37.34% increase compared to ¥1,820,394,804.35 in 2022[125]. - The investment activities cash outflow increased significantly by 288.40% to ¥3,423,952,676.84, compared to ¥881,544,180.29 in 2022[126]. - The company reported a significant increase in cash flow from operating activities, indicating strong operational performance[148]. - The company has ensured that the disclosure of raised funds usage is timely, truthful, accurate, and complete, with no violations reported[161].